Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE
2024-518272-30-00Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypoadrenocorticism comparing Hydrocortisone arm with Placebo arm (2 arms). Primary endpoint: Ecological momentary assessment of MFI-20 General Fatigue during stress. Started Jun 2022; status: completed.
02
Drugs
Alkindi Sprinkle
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on 2024-518272-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518272-30-00.